Skip to main content

Day: March 1, 2024

Cerro Grande Mining Corporation Announces its First Fiscal Quarter ended December 31, 2023 results compared to the same period in 2022.

TORONTO, Feb. 29, 2024 (GLOBE NEWSWIRE) — Cerro Grande Mining Corporation (the “Company” or “CEG”) (CSE:CEG) reported its unaudited results for the first fiscal quarter ended December 31, 2023 compared to the same quarter in 2022. These financial statements and MD&A have been filed on SEDAR and the Company refers the reader to those materials for additional information. Cerro Grande Mining Corporation is an exploration and development company with properties and activities currently focused in Chile. Cautionary Statement on Forward-looking Information: This news release contains “forward-looking information”, which may include, but is not limited to, statements with respect to the future financial or operating performance of CEG. Often, but not always, forward-looking statements can be identified by the use of...

Continue reading

Li Auto Inc. February 2024 Delivery Update

BEIJING, China, March 01, 2024 (GLOBE NEWSWIRE) — Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that the Company delivered 20,251 vehicles in February 2024, up 21.8% year over year. The cumulative deliveries of Li Auto vehicles reached 684,780 as of the end of February 2024. “Even with the impact of Chinese New Year and some trims of Li L series models sold out as we prepare for switching to new models, our average daily delivery in February (excluding the eight-day Chinese New Year holiday period) still increased significantly compared with that of February 2023. We are scheduled to officially launch the long-expected Li MEGA and 2024 Li L series models at our spring launch event this afternoon. Li MEGA is a revolutionary model meticulously crafted...

Continue reading

ALLDATA Europe adds three more vehicle manufacturers to workshop portal – bringing total to 36

Europe’s technicians can now access ALLDATA repair data for Abarth, Chrysler and Tesla.Tesla Repair InformationALLDATA Repair subscribers can now access genuine Tesla repair data, for a total of 36 vehicle manufacturersImproved search listALLDATA Repair subscribers can now quickly locate hybrid and electric vehicle (EV) repair data through an improved ‘component tree’ search list.COLOGNE, Germany, Feb. 29, 2024 (GLOBE NEWSWIRE) — ALLDATA Repair subscribers across Europe can now access original OEM repair information from Abarth, Chrysler and Tesla. With these agreements, the number of vehicle manufacturers (VMs) available from ALLDATA Repair has reached 36. This means independent technicians can gain genuine technical data for 96% of vehicles on the road today. Additionally, ALLDATA Repair subscribers can now...

Continue reading

McEwen Mining: 2023 Year End and Q4 Results

2023 Net income $1.15/share vs. 2022 net loss $1.71/share TORONTO, Feb. 29, 2024 (GLOBE NEWSWIRE) — McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) today reported its fourth quarter (“Q4”) and full year 2023 financial and operational results. Net income for the year was $54.7 million or $1.15 per share versus a 2022 net loss of $81.1 million or $1.71 per share! Gold production at the Fox Complex and Gold Bar mine came in just above the low end of guidance and San José just below guidance. However, cash costs(1) and AISC(1) per ounce remain 12-18% higher than guided and need more attention. Growth Plans for 2024 “Our biggest single asset with the greatest near-term potential to increase our share value is our 48% owned subsidiary McEwen Copper. Its 2nd and 3rd largest shareholders are global giants, Rio Tinto and Stellantis, the world’s...

Continue reading

Humacyte, Inc. Announces Pricing of $40.2 Million Public Offering of Common Stock

DURHAM, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today announced today announced the pricing of an underwritten public offering of 13,400,000 shares of its common stock at a public offering price of $3.00 per share. The aggregate gross proceeds from this offering are expected to be $40.2 million, before deducting underwriting discounts and commissions and other offering expenses payable by Humacyte. The closing of the offering is expected to occur on or about March 5, 2024, subject to the satisfaction of customary closing conditions. In addition, Humacyte has granted the underwriters an option for a period of 30 days to purchase up to an additional 2,010,000 shares of Humacyte’s...

Continue reading

Celldex Therapeutics Announces Pricing of Upsized $400 Million Public Offering of Common Stock

HAMPTON, N.J., Feb. 29, 2024 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX) today announced the pricing of an upsized underwritten public offering of 8,520,000 shares of its common stock at a public offering price of $47.00 per share. All of the shares to be sold in the offering are to be sold by Celldex. In connection with the offering, Celldex has granted the underwriters a 30-day option to purchase up to an additional 1,278,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The Company expects to receive gross proceeds from the offering, excluding the exercise of the underwriters’ option, if any, of approximately $400.4 million, excluding underwriting discounts and commissions and other offering-related expenses. The offering is expected...

Continue reading

PlantX Reports Financial Results for Q3 2024

VANCOUVER, British Columbia, Feb. 29, 2024 (GLOBE NEWSWIRE) — PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) (“PlantX” or the “Company”), the digital face of the plant-based community, operating a one-stop shop for plant-based products, reported its condensed interim consolidated financial results for the period ended December 31, 2023 (“Q3 2024”). All amounts are reported in Canadian dollars unless otherwise stated. Q3 2024 Financial Results During Q3 2024, the Company demonstrated consistent growth and operational efficiency, with revenue totaling $ 9,184,678 and a net loss of $ 5,699,913. The Company’s strategic focus on profitability was reinforced by a 5% increase in gross profit margin compared to the same period in 2022. Operating expenses notably decreased by $1,829,856 compared to the same period in...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.